Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial

Public

Shared by NobleBlocks on Aug 3, 2018 • 12:00 AM UTC

Authors:

Juliette Lambert

Cécile Pautas

Christine Terré

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!